BusinessMYnd Analytics Receives IRB Approvals for SMART-MD Replication TrialBy Nasdaq OMXApr 1, 2016, 12:30 PM UTC
BusinessProteostasis Therapeutics, Inc. Presents New Data Demonstrating Potential for Genotype-Agnostic and Combination Therapies for People with Cystic FibrosisBy Nasdaq OMXMar 30, 2016, 6:08 PM UTC
BusinessSummit to Present Additional Data From Phase 2 CoDIFy Trial Showing Ridinilazole’s Statistical Superiority Over Vancomycin in Sustained Clinical Response was Driven by Marked Reduction in Recurrence of C. difficile InfectionBy Nasdaq OMXMar 29, 2016, 1:25 PM UTC
BusinessSANUWAVE Announces 24-Week Data From Its Pivotal Trials Investigating the Use of dermaPACE for the Treatment of Diabetic Foot UlcersBy Nasdaq OMXMar 24, 2016, 1:00 PM UTC
BusinessAgile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial ResultsBy Nasdaq OMXMar 9, 2016, 9:10 PM UTC
BusinessAgile Therapeutics to Present at the 28th Annual ROTH ConferenceBy Nasdaq OMXMar 3, 2016, 9:15 PM UTC
BusinessOcera to Present at the Cowen and Company 36th Annual Health Care ConferenceBy Nasdaq OMXFeb 29, 2016, 9:05 PM UTC
BusinessOncothyreon Announces First Patient Dosed in Randomized Phase 2 ONT-380 Combination Trial in Patients with HER2-Positive Breast CancerBy Nasdaq OMXFeb 29, 2016, 1:00 PM UTC
